期刊文献+

低分子肝素在肾病综合征中的应用 被引量:1

下载PDF
导出
摘要 肾病综合征(NS)患者易并发血栓栓塞(TE)。低分子肝素(LMWH)作为新一代抗凝剂,应用于NS不仅能防治TE,而且具有非抗凝性肾脏保护作用。笔者就LMWH在NS中的应用作一概述。
作者 张莉 魏日胞
出处 《军医进修学院学报》 CAS 北大核心 2006年第6期478-480,共3页 Academic Journal of Pla Postgraduate Medical School
  • 相关文献

参考文献10

  • 1Hong SY,Yang DH.Lipoprotein(a)levels and fibrinolytic activity in patients with nephrotic syndrome[J].Nephron,1995,69(1):125-130.
  • 2Yeo Wook Yun,Sun-Jin You,Dong Kyu Lee,et al.Cerebral infarction as a complication of nephrotic syndrome:A case report with a review of the literature[J].J Korean Med Sci,2004,19:315-319.
  • 3Buller HR,Agnelli G,Hull RD,et al.Antithrombotic therapy for venous thromboembolic disease:the seventh ACCP conference on antithrombotic and thrombolytic therapy[J].Chest,2004,126(suppl):401S-428S.
  • 4Farooq V,Hegarty J,Chandrasekar T,et al.Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease[J].Am J Kidney Dis,2004,43(3):531-537.
  • 5Nagge J,Crowther M,Hirsh J.Is impaired renal function a contraindication to the use of low-molecular-weight heparin[J] ? Arch Intern Med,2002,162(22):2605-2609.
  • 6Duplaga BA,Rivers CW,Nutescu E.Dosing and monitoring of low-molecular-weight heparins in special populations[J].Pharmacotherapy,2001,21:218-234.
  • 7Samama MM,Gerotziafas GT.Comparative pharmacokinetics of LMWHs[J].Semin Thromb Hemost,2000,26:S31-S38.
  • 8Greaves M.Limitations of the laboratory monitoring of heparin therapy[J].Thromb Haemost,2002,87:163-164.
  • 9Weitz JI.New anticoagulants for treatment of venous thromboembolism[J].Circulation,2004,110(9 Suppl 1):119-126.
  • 10Becker RC,Rusconi C,Sullenger B.Nucleic acid aptamers in therapeutic anticoagulation.Technology,development and clinical application[J].Thromb-Haemost,2005,93(6):1014-1020.

同被引文献39

  • 1贺丽生,谌贻璞.吗替麦考酚酯联合激素治疗膜性肾病的临床观察[J].临床肾脏病杂志,2007,7(1):1-4. 被引量:3
  • 2王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262.
  • 3Narasimhan B, Chacko B, John GT, et al. Characterization of kid- ney lesions in Indian adults : towards a renal biopsy registry [ J ]. J Nephrol, 2006,19 ( 2 ) : 205 -210.
  • 4Chang JH, Kim DK, Kim HW, et al. Changing prevalence of glo- merular diseases in Korean adults : a review of 20 years of experi- ence [ J ]. N ephrol Dial Transpl ant, 2009,24 ( 8 ) : 2406 -2410.
  • 5Swaminathan S, Leung N, Lager DJ, et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study [ J ]. Clin J Am Soc Nephrol, 2006,1 (3) :483-487.
  • 6Kurnatowska I,Jedrzejka D, Malyska A,et al. Trends in the inci- dence of biopsy- proven glomerular diseases in the adult population in central Poland in the years 1990-2010 [J]. Kidney Blood Press Res ,2012,35 (4) :254-258.
  • 7Ossareh S, Asgari M, Abdi E,et al. Renal biopsy findings in Iran: case series report from a referral kidney center[ J]. Int Urol Neph- ro1,2010,42 (4) : 1031-1040.
  • 8Sugiyama H, Yokoyam H, Sato H, et al. Japan Renal Biopsy Regis- try:the first nationwide, web-based, and prospective registry system of renal biopsies in Japan [ J ]. Clin Exp Nephrol, 2011,15 (4) : 493 -503.
  • 9Zuo K, Wu Y, Li SJ, et al. Long term outcome and prognostic fac- tors of idiopathic membranous nephropathy in the Chinese popula- tion[ J]. Clin Nephrol,2013,79(6) :445-453.
  • 10Cattran D. Management of membranous nephropathy: when and what for treatment [J]. J Am Soe Nephml, 2005, 16 (5): 1188-1194.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部